Blood cadmium levels and Alzheimer's disease mortality risk in older US adults

Environmental Health: A Global Access Science Source

Volumn 15, Issue 1, 2016, Pages

  Min, Jin Young ^a   Min, Kyoung Bok ^a  

^a Seoul National University   (South Korea)

Author keywords

Alzheimer disease; Cadmium; Environmental; NHANES; Population health

Indexed keywords

CADMIUM; POLLUTANT;

ADULT; BASELINE SURVEY; CADMIUM; DISEASE; HEALTH RISK; MORTALITY RISK; PARTICIPATORY APPROACH; PUBLIC HEALTH; QUESTIONNAIRE SURVEY; RISK FACTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CADMIUM BLOOD LEVEL; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; ICD-10; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SURVIVAL; UNITED STATES; VERY ELDERLY; ADVERSE EFFECTS; ANALYSIS; BLOOD; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; NUTRITION; POLLUTANT; RISK FACTOR;

UNITED STATES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CADMIUM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; RISK FACTORS; UNITED STATES;

EID: 84975144716     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/s12940-016-0155-7     Document Type: Article

References (34)

1. Perry G, Friedman R, Shaw G, Chau V. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci U S A. 1987;84(9):3033-6.
2. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 1999;399(6738 Suppl):A23-31.
3. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10(9):819-28.
4. Migliore L, Coppede F. Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat Res. 2009;674(1-2):73-84.
5. Agency for Toxic S, Disease R. Toxicological profile for cadmium. September 2008 [online]. 2008. Available at URL: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=48&tid=15. Accessed 12 Jun 2016.
6. Satarug S, Baker JR, Urbenjapol S, Haswell-Elkins M, Reilly PE, Williams DJ, Moore MR. A global perspective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicol Lett. 2003;137(1-2):65-83.
7. Kepp KP. Bioinorganic chemistry of Alzheimer's disease. Chem Rev. 2012;112(10):5193-239.
8. Wang B, Du Y. Cadmium and its neurotoxic effects. Oxidative Med Cell Longev. 2013;2013:898034.
9. Chen L, Liu L, Huang S. Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5. Free Radic Biol Med. 2008;45(7):1035-44.
10. Lopez E, Figueroa S, Oset-Gasque MJ, Gonzalez MP. Apoptosis and necrosis: two distinct events induced by cadmium in cortical neurons in culture. Br J Pharmacol. 2003;138(5):901-11.
11. Xu B, Chen S, Luo Y, Chen Z, Liu L, Zhou H, Chen W, Shen T, Han X, Chen L et al. Calcium signaling is involved in cadmium-induced neuronal apoptosis via induction of reactive oxygen species and activation of MAPK/mTOR network. PLoS One. 2011;6(4):e19052.
12. Emsley CL, Gao S, Li Y, Liang C, Ji R, Hall KS, Cao J, Ma F, Wu Y, Ying P et al. Trace element levels in drinking water and cognitive function among elderly Chinese. Am J Epidemiol. 2000;151(9):913-20.
13. Gao S, Jin Y, Unverzagt FW, Ma F, Hall KS, Murrell JR, Cheng Y, Shen J, Ying B, Ji R et al. Trace element levels and cognitive function in rural elderly Chinese. J Gerontol A Biol Sci Med Sci. 2008;63(6):635-41.
14. Viaene MK, Masschelein R, Leenders J, De Groof M, Swerts LJ, Roels HA. Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study. Occup Environ Med. 2000;57(1):19-27.
15. Basun H, Forssell LG, Wetterberg L, Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect. 1991;3(4):231-58.
16. Lui E, Fisman M, Wong C, Diaz F. Metals and the liver in Alzheimer's disease. An investigation of hepatic zinc, copper, cadmium, and metallothionein. J Am Geriatr Soc. 1990;38(6):633-9.
17. Panayi AE, Spyrou NM, Iversen BS, White MA, Part P. Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J Neurol Sci. 2002;195(1):1-10.
18. Centers for Disease Control and Prevention NCfHS. National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2006. Available: http://www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm. Accessed 12 Jun 2016.
19. National Center for Health Statistics OoAaE. Public-use Linked Mortality File, 2015. Hyattsville, Maryland. 2015. (Available at the following address: http://www.cdc.gov/nchs/data-access/data-linkage/mortality.htm. Accessed 12 Jun 2016.
20. Prince M, Albanese E, Guerchet M, Prina M. World Alzheimer Report 2014: Dementia and risk reduction: An analysis of protective and modifiable risk factors. London: Alzheimer's Disease International; 2014.
21. Adlard PA, Bush AI. Metals and Alzheimer's disease. J Alzheimers Dis. 2006;10(2-3):145-63.
22. Drago D, Bolognin S, Zatta P. Role of metal ions in the abeta oligomerization in Alzheimer's disease and in other neurological disorders. Curr Alzheimer Res. 2008;5(6):500-7.
23. Tougu V, Karafin A, Palumaa P. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide. J Neurochem. 2008;104(5):1249-59.
24. Jiang LF, Yao TM, Zhu ZL, Wang C, Ji LN. Impacts of Cd(II) on the conformation and self-aggregation of Alzheimer's tau fragment corresponding to the third repeat of microtubule-binding domain. Biochim Biophys Acta. 2007;1774(11):1414-21.
25. Syme CD, Viles JH. Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease. Biochim Biophys Acta. 2006;1764(2):246-56.
26. Yano K, Hirosawa N, Sakamoto Y, Katayama H, Moriguchi T. Aggregations of amyloid beta-proteins in the presence of metal ions. Toxicol Lett. 2003;144:s134.
27. Bush AI, Pettingell WH, Multhaup G, D Paradis M, Vonsattel JP, Gusella JF, Beyreuther K, Masters CL, Tanzi RE. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (New York, NY). 1994;265(5177):1464-7.
28. Li X, Lv Y, Yu S, Zhao H, Yao L. The effect of cadmium on Abeta levels in APP/PS1 transgenic mice. Exp Ther Med. 2012;4(1):125-30.
29. Notarachille G, Arnesano F, Calo V, Meleleo D. Heavy metals toxicity: effect of cadmium ions on amyloid beta protein 1-42. Possible implications for Alzheimer's disease. Biometals. 2014;27(2):371-88.
30. Adams SV, Newcomb PA. Cadmium blood and urine concentrations as measures of exposure: NHANES 1999-2010. J Expo Sci Environ Epidemiol. 2014;24(2):163-70.
31. Amzal B, Julin B, Vahter M, Wolk A, Johanson G, Akesson A. Population toxicokinetic modeling of cadmium for health risk assessment. Environ Health Perspect. 2009;117(8):1293-301.
32. Järup L, Rogenfelt A, Elinder CG, Nogawa K, Kjellström T. Biological half-time of cadmium in the blood of workers after cessation of exposure. J Expo Sci Environ Epidemiol. 1983;9(4):327-31.
33. Romero JP, Benito-León J, Mitchell AJ, Trincado R, Bermejo-Pareja F. Under reporting of dementia deaths on death certificates using data from a population-based study (NEDICES). J Alzheimers Dis. 2014;39(4):741-8.
34. Go SM, Lee KS, Seo SW, Chin J, Kang SJ, Moon SY, Na DL, Cheong HK. Survival of Alzheimer's disease patients in Korea. Dement Geriatr Cogn Disord. 2013;35(3-4):219-28.